Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry (Review)
- PMID: 24765135
- PMCID: PMC3997732
- DOI: 10.3892/ol.2014.1912
Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry (Review)
Abstract
Estrogen receptors [ERs (subtypes α and β)], classified as a nuclear receptor super family, are intracellular proteins with an important biological role as the transcription factors for estrogen target genes. For ER-induced transcription, an interaction must exist between ligand and coregulators. Coregulators may stimulate (coactivators) or inhibit (corepressors) transcription, following binding with a specific region of the gene, called the estrogen response element. Misbalanced activity of coregulators or higher ligand concentrations may cause increased cell proliferation, resulting in specific types of cancer. These are exhibited as overexpression of ER proteins. Breast cancer currently ranks first in the incidence and second in the mortality of cancer in females worldwide. In addition, 70% of breast tumors are ERα positive and the importance of these proteins for diagnostic use is indisputable. Early diagnosis of the tumor and its classification has a large influence on the selection of appropriate therapy, as ER-positive tumors demonstrate a positive response to hormonal therapy. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI TOF MS) has been hypothesized to have great potential, as it offers reliable, robust and efficient analysis methods for biomarker monitoring and identification. The present review discusses ER protein analysis by MALDI TOF MS, including the crucial step of protein separation.
Keywords: cancer; estrogen receptor; estrogen response element; matrix-assisted laser desorption/ionization time of flight.
Figures


Similar articles
-
Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.J Mol Endocrinol. 2004 Oct;33(2):387-410. doi: 10.1677/jme.1.01541. J Mol Endocrinol. 2004. PMID: 15525597
-
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.Breast Cancer Res. 2014 Jun 16;16(3):R63. doi: 10.1186/bcr3676. Breast Cancer Res. 2014. PMID: 24935269 Free PMC article.
-
Early identification of microorganisms in blood culture prior to the detection of a positive signal in the BACTEC FX system using matrix-assisted laser desorption/ionization-time of flight mass spectrometry.J Microbiol Immunol Infect. 2015 Aug;48(4):419-24. doi: 10.1016/j.jmii.2013.10.006. Epub 2013 Dec 30. J Microbiol Immunol Infect. 2015. PMID: 24388584
-
Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review.Microorganisms. 2021 Jul 19;9(7):1536. doi: 10.3390/microorganisms9071536. Microorganisms. 2021. PMID: 34361971 Free PMC article. Review.
-
Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.Molecules. 2020 Oct 17;25(20):4775. doi: 10.3390/molecules25204775. Molecules. 2020. PMID: 33080897 Free PMC article. Review.
Cited by
-
Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians.Breast Cancer (Dove Med Press). 2017 Jan 24;9:45-49. doi: 10.2147/BCTT.S125652. eCollection 2017. Breast Cancer (Dove Med Press). 2017. PMID: 28182136 Free PMC article.
-
Multivalent aptamer/gold nanoparticle-modified graphene oxide for mass spectrometry-based tumor tissue imaging.Sci Rep. 2015 May 14;5:10292. doi: 10.1038/srep10292. Sci Rep. 2015. PMID: 25973571 Free PMC article.
-
Classification of cancer cell lines using matrix-assisted laser desorption/ionization time‑of‑flight mass spectrometry and statistical analysis.Int J Mol Med. 2017 Oct;40(4):1096-1104. doi: 10.3892/ijmm.2017.3083. Epub 2017 Jul 27. Int J Mol Med. 2017. PMID: 28765873 Free PMC article.
-
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.Onco Targets Ther. 2020 Nov 27;13:12255-12268. doi: 10.2147/OTT.S263998. eCollection 2020. Onco Targets Ther. 2020. PMID: 33273831 Free PMC article.
-
Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer.Proteomes. 2022 Oct 21;10(4):35. doi: 10.3390/proteomes10040035. Proteomes. 2022. PMID: 36278695 Free PMC article. Review.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. - PubMed
-
- Patani N, Martin LA, Dowsett M. Biomarkers for the clinical management of breast cancer: international perspective. Int J Cancer. 2013;133:1–13. - PubMed
-
- Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources